Peter Gal, Vlasta Perze�¾ova, Tomas Vasilenko, Martin Novotny, Ivan Kovac, Martina Pilatova, Pavol Szabo, Lenka Varinska, Hans-Joachim Gabius and Karel Smetana Jr
Pavol Jozef Safarik University, Slovak Republic
East-Slovak Institute of Cardiovascular Diseases, Slovak Republic
Charles University, Czech Republic
Ludwig-Maximilians-University Munich, Germany
Scientific Tracks Abstracts: J Pharma Care Health Sys
It is well known that wound repair efficiency in elderly is reduced, and the skin becomes more fragile and susceptible to trauma. Estrogen deprivation in post-menopausal women can be responsible for many age-related processes including poor wound healing. Guided by previous observations that estradiol accelerates re-epithelialization via the estrogen receptor (ER)-�², the question whether selective ER agonists (PPTâ��ER-�± agonist; DPNâ��ER-�² agonist) affect the expression of basic proliferation and differentiation markers (Ki-67, keratins-10, -14, and -19, galectin-1, Sox-2) of keratinocytes was answered using the model of HaCaT cells. In parallel, ovariectomised rats were treated daily with ER modulator, and wound tissue was removed 21 days after wounding and routinely processed for basic histology. Our study revealed that HaCaT keratinocytes express both ER-�± and -�², thus being suited for study of ER agonists on epidermis regeneration. Stimulation of ER-�± led to a protein expression pattern as seen in control culture with moderate expression of Ki-67. On the other hand, activation of ER-�² led to an increase in cell proliferation and keratin-19 expression as well as to a decrease of galectin-1 expression. Fittingly, rat wounds treated with the ER-�² agonist showed the most prominent progress of epidermis regeneration. Thus, we herein add information on how estrogens affect expression patterns of selected markers en route to modulate keratinocyte proliferation and differentiation with direct impact on wound healing.
Peter Gal has completed his PhD at the age of 30 years from The University of Veterinary Medicine and Pharmacy in Kosice, Slovak Republic. He is doing his second PhD thesis at the Charles University, 1st Faculty of Medicine, Prague, Czech Republic. He has published more than 35 papers in reputed journals.
Email: galovci@yahoo.com
